Literature DB >> 16765439

T-type calcium channels and tumor proliferation.

Amith Panner1, Robert D Wurster.   

Abstract

The role of T-type Ca2+ channels in proliferation of tumor cells is reviewed. Intracellular Ca2+ is important in controlling proliferation as evidenced by pulses, or oscillations, of intracellular Ca2+ which occur in a cell cycle-dependent manner in many tumor cells. Voltage-gated calcium channels, such as the T-type Ca2+ channel, are well suited to participate in such oscillations due to their unique activation/inactivation properties. Expression of the T-type Ca2+ channels has been reported in numerous types of tumors, and has been shown to be cell cycle-dependent. Overexpression of the alpha1 subunit of T-type Ca2+ channels in human astrocytoma, neuroblastoma and renal tumor cell lines enhanced proliferation of these cells. In contrast, targeting of the alpha1 subunit of the T-type calcium channel via siRNA decreased proliferation of these cells. A Ca2+ oscillatory model is proposed involving potassium channels, Ca2+ stores and Ca2+ exchangers/transporters. A review of T-type channel blockers is presented, with a focus on mibefradil-induced inhibition of proliferation. The development of newer blockers with higher selectivity and less potential side effects are discussed. The conclusion reached is that calcium channel blockers serve as a potential therapeutic approach for tumors whose proliferation depends on T-type calcium channel expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16765439     DOI: 10.1016/j.ceca.2006.04.029

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  50 in total

Review 1.  Ca(2+) signaling by T-type Ca(2+) channels in neurons.

Authors:  Lucius Cueni; Marco Canepari; John P Adelman; Anita Lüthi
Journal:  Pflugers Arch       Date:  2008-09-11       Impact factor: 3.657

Review 2.  Low-voltage-activated T-type Ca2+ channel inhibitors as new tools in the treatment of glioblastoma: the role of endostatin.

Authors:  Yuan Zhang; Hua Wang; Zhiyuan Qian; Bo Feng; Xianyang Zhao; Xinghong Jiang; Jin Tao
Journal:  Pflugers Arch       Date:  2014-01-10       Impact factor: 3.657

3.  Inhibition of human recombinant T-type calcium channels by N-arachidonoyl 5-HT.

Authors:  Andrew J Gilmore; Marika Heblinski; Aaron Reynolds; Michael Kassiou; Mark Connor
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

4.  High expression of calcium channel subtypes in uterine fibroid of patients.

Authors:  Xiaoping Ke; Zhongping Cheng; Xiaoyan Qu; Hong Dai; Wenchao Zhang; Zi-Jiang Chen
Journal:  Int J Clin Exp Med       Date:  2014-05-15

Review 5.  T-type Ca2+ channels and the urinary and male genital tracts.

Authors:  C H Fry; R I Jabr
Journal:  Pflugers Arch       Date:  2014-01-25       Impact factor: 3.657

Review 6.  Modulation of T-type calcium channels by bioactive lipids.

Authors:  Jean Chemin; Magali Cazade; Philippe Lory
Journal:  Pflugers Arch       Date:  2014-02-16       Impact factor: 3.657

7.  Complex modulation of Ca(v)3.1 T-type calcium channel by nickel.

Authors:  Olena V Nosal; Olga P Lyubanova; Valeri G Naidenov; Yaroslav M Shuba
Journal:  Cell Mol Life Sci       Date:  2012-12-19       Impact factor: 9.261

Review 8.  Calcium influx pathways in breast cancer: opportunities for pharmacological intervention.

Authors:  I Azimi; S J Roberts-Thomson; G R Monteith
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

Review 9.  Calcium signaling and T-type calcium channels in cancer cell cycling.

Authors:  James T Taylor; Xiang-Bin Zeng; Jonathan E Pottle; Kevin Lee; Alun R Wang; Stephenie G Yi; Jennifer A S Scruggs; Suresh S Sikka; Ming Li
Journal:  World J Gastroenterol       Date:  2008-08-28       Impact factor: 5.742

10.  Prevention of lens epithelial cell growth in vitro using mibefradil-containing PLGA micro particles.

Authors:  Arne Weidmann; Sabine Kwittner; Ria Beck; Joachim Teller; Ludwig Jonas; J Barbara Nebe
Journal:  Open Ophthalmol J       Date:  2008-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.